Rare cancers research program support services for congressionally directed medical research programs (cdmrp)
Ended Awarded Last action
- Contract number
- W81XWH22F0146
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $204,924
Award facts
- Opportunity
-
- W81XWH17R0036 Solicitation number
- Contract value 83% obligated
- $247,829.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Two Step
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$42,905 | |
| Supplemental Agreement for work within scope | $8,497 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $164,101 | |
| Original award | $75,231 |
About this award
Leidos, Inc., operating as Saic under its Leidos Services segment, has been awarded a $247,829 delivery order against the Chief Information Officer - Solutions and Partners 3 (CIO-SP3) governmentwide acquisition contract (GWAC) vehicle to provide rare cancers research program support services for the Defense Health Agency's Congressionally Directed Medical Research Programs (CDMRP). Work will be performed at Fort Detrick, Maryland over a one year period ending in July 2023. Pricing is set at cost plus fixed fee. No socioeconomic designations apply to this order. The CDMRP supports innovative research aimed at improving clinical outcomes for rare diseases through programs tailored to specific cancer types. Leidos will leverage its scientific and technical expertise to assist the agency in managing these initiatives.
Quick answers
Who was awarded contract W81XWH22F0146?
W81XWH22F0146 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on July 5, 2022.
How much is contract W81XWH22F0146 worth?
The government has obligated $204,924 on W81XWH22F0146. Its current value, with exercised options, is $247,829.
Is contract W81XWH22F0146 an order under another contract?
Yes. W81XWH22F0146 is a delivery order under W81XWH17D0025, an indefinite delivery contract.
Was contract W81XWH22F0146 competed?
The extent of competition for W81XWH22F0146 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award